Atlas Trials

KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)

Clinical trial NCT07406633 · RECRUITING

Trial details

NCT number
NCT07406633
Sponsor
Kumquat Biosciences Inc.
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
GIST - Gastrointestinal Stromal TumorGISTGIST Metastatic CancerGastro Intestinal Stromal TumourGastrointestinal Tumors
Start date
2026-06-23
Primary completion
2027-10-01
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.